Current:Home > NewsTrump expected to attend New York fraud trial again Thursday as testimony nears an end -Quantum Finance Bridge
Trump expected to attend New York fraud trial again Thursday as testimony nears an end
View
Date:2025-04-16 15:44:20
NEW YORK (AP) — He’s been a frustrated observer, a confrontational witness and a heated commentator outside the courtroom door. Now former President Donald Trump is poised to return to his civil business fraud trial again, first to watch and then to serve as star witness for his own defense.
With testimony winding down after more than two months, court officials and Trump’s attorneys and aides have indicated that the Republican 2024 presidential front-runner is expected to show up voluntarily as a spectator Thursday, when his legal team is calling an accounting professor to testify about some financial topics important to the case.
Then Trump himself is scheduled to take the stand Monday, for a second time.
Even while campaigning to reclaim the presidency and fighting four criminal cases, Trump is devoting a lot of attention to the New York lawsuit. The case is putting his net worth on trial, scrutinizing the real estate empire that first built his reputation, and threatening to block him from doing business in his native state.
New York Attorney General Letitia James’s suit accuses Trump, his company and some executives of misleading banks and insurers by giving them financial statements full of inflated values for such signature assets as his Trump Tower penthouse and Mar-a-Lago, the Florida club where he now lives. The statements were provided to help secure deals — including loans at attractive interest rates available to hyperwealthy people — and some loans required updated statements each year.
Trump denies any wrongdoing, and he posits that the statements’ numbers actually fell short of his wealth. He has downplayed the documents’ importance in getting deals, saying it was clear that lenders and others should do their own analyses. And he claims the case is a partisan abuse of power by James and Judge Arthur Engoron, both Democrats.
The former president has regularly railed about the case on his Truth Social platform. “Happy Banks and Insurance Companies, NO VICTIMS, GREAT FINANCIAL STATEMENTS, Perfect Disclaimer Clause - BUT A CORRUPT ATTORNEY GENERAL AND JUDGE!!!” read a typical comment this week.
Trump isn’t required to attend the trial when he’s not on the stand. But going to court affords him a microphone — in fact, many of them, on the news cameras positioned in the hallway. He often stops on his way into and out of the proceedings, which cameras can’t film, to expostulate and to cast various developments as victories.
His out-of-court remarks got him fined $10,000 Oct. 26, when Engoron decided Trump had violated a gag order that prohibits participants in the trial from commenting publicly on court staffers. Trump’s lawyers are appealing the gag order.
James hasn’t let Trump go unanswered, showing up to court herself on the days when he’s there and making her own comments on social media and the courthouse steps. (Lawyers in the case have been told not to make press statements in the hallway, but the former president has been allowed to do so.)
“Here’s a fact: Donald Trump has engaged in years of financial fraud. Here’s another fact: When you break the law, there are consequences,” her office wrote this week on X, formerly Twitter.
While the non-jury trial is airing claims of conspiracy, insurance fraud and falsifying business records, Engoron ruled beforehand that Trump and other defendants engaged in fraud. He ordered that a receiver take control of some of Trump’s properties, but an appeals court has held off that order for now.
At trial, James is seeking more than $300 million in penalties and a prohibition on Trump and other defendants doing business in New York.
It’s not clear exactly when testimony will wrap up, but it’s expected before Christmas. Closing arguments are scheduled in January, and Engoron is aiming for a decision by the end of that month.
veryGood! (33)
Related
- The Grammy nominee you need to hear: Esperanza Spalding
- Florida bans direct-to-consumer auto sales but leaves carve-out for Tesla
- COP’s Postponement Until 2021 Gives World Leaders Time to Respond to U.S. Election
- This Week in Clean Economy: GOP Seizes on Solyndra as an Election Issue
- Residents worried after ceiling cracks appear following reroofing works at Jalan Tenaga HDB blocks
- Human composting: The rising interest in natural burial
- California could ban certain food additives due to concerns over health impacts
- A veterinarian says pets have a lot to teach us about love and grief
- Skins Game to make return to Thanksgiving week with a modern look
- Ranking Oil Companies by Climate Risk: Exxon Is Near the Top
Ranking
- South Korean president's party divided over defiant martial law speech
- Exxon Loses Appeal to Keep Auditor Records Secret in Climate Fraud Investigation
- Selling Sunset Reveals What Harry Styles Left Behind in His Hollywood House
- Sickle cell patient's success with gene editing raises hopes and questions
- Person accused of accosting Rep. Nancy Mace at Capitol pleads not guilty to assault charge
- Bob Huggins resigns as West Virginia men's basketball coach after DUI arrest in Pittsburgh
- Blinken arrives in Beijing amid major diplomatic tensions with China
- Patriots cornerback Jack Jones arrested at Logan Airport after 2 loaded guns found in carry-on luggage
Recommendation
Nevada attorney general revives 2020 fake electors case
Private opulence, public squalor: How the U.S. helps the rich and hurts the poor
‘Essential’ but Unprotected, Farmworkers Live in Fear of Covid-19 but Keep Working
Q&A: 50 Years Ago, a Young Mother’s Book Helped Start an Environmental Revolution
DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
What is Babesiosis? A rare tick-borne disease is on the rise in the Northeast
Sickle cell patient's success with gene editing raises hopes and questions
How poverty and racism 'weather' the body, accelerating aging and disease